Howard C. Margolese, MSc, MD, CM, FRCPC

Department of Psychiatry, McGill University, Montreal, Quebec, Canada

  • 5Articles
  • 7KReads
  • 2002–2025Active
  • 40Collaborators
  • 19Citations

About

Howard C. Margolese, MSc, MD, CM, FRCPC, is affiliated with the Department of Psychiatry at McGill University in Montreal, Quebec, Canada. He has contributed to Psychiatrist.com from 2002 to 2025, focusing on topics such as depression, bipolar disorder, neurology, and schizophrenia/schizoaffective disorders. His frequent co-authors include Soham Rej, Alexandra Anacleto, Anthony J. Gifuni, Boadie W. Dunlop, and Caitrin Armstrong.

Publications

JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
PCC
Letter to the Editor

Diabetes Insipidus Secondary to Combination Atypical Antipsychotic and Lithium Use in a Bipolar Disorder Patient: A Case Report

July 21, 2011

, ,
JCP
Letter to the Editor

Alternative Pharmacotherapy for Trichotillomania: A Report of Successful Bupropion Use

September 1, 2004

,
JCP
Original Research

Depression and Dysphoria in Adult and Adolescent Patients With Tourette's Disorder Treated With Risperidone

November 1, 2002

, ,
JCP
Letter to the Editor

Topiramate Produced Weight Loss Following Olanzapine-Induced Weight Gain in Schizophrenia

November 1, 2002

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe